Detected ·
Remepy
$36M—
Remepy, a New York-based biotech pioneering Hybrid Drugs (combining pharmaceuticals with AI-driven therapeutic apps), raised $36M in Series A co-led by O.G. Venture Partners and M Ventures to advance its Parkinson's disease program Hybridopa into Phase III.
- Website
- www.remepy.com
- linkedin.com/company/remepy
- Amount
- $36 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-21 12:51:17 UTC
- Signal ID
- ac69bbad-7585-4051-9b49-b586f5b27303
As the API returns it
{
"id": "ac69bbad-7585-4051-9b49-b586f5b27303",
"created_at": "2026-08-21T12:51:17.522594Z",
"company_name": "Remepy",
"company_website_url": "www.remepy.com",
"company_linkedin_url": "https://www.linkedin.com/company/remepy",
"event_type": "funding",
"funding_amount": 36000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Remepy, a New York-based biotech pioneering Hybrid Drugs (combining pharmaceuticals with AI-driven therapeutic apps), raised $36M in Series A co-led by O.G. Venture Partners and M Ventures to advance its Parkinson's disease program Hybridopa into Phase III.*"
}